Intervention Review

You have free access to this content

Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions

  1. Roger E Thomas1,*,
  2. Tom Jefferson2,
  3. Toby J Lasserson3

Editorial Group: Cochrane Acute Respiratory Infections Group

Published Online: 22 JUL 2013

Assessed as up-to-date: 31 MAR 2013

DOI: 10.1002/14651858.CD005187.pub4


How to Cite

Thomas RE, Jefferson T, Lasserson TJ. Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD005187. DOI: 10.1002/14651858.CD005187.pub4.

Author Information

  1. 1

    University of Calgary, Department of Family Medicine, Faculty of Medicine, Calgary, Alberta, Canada

  2. 2

    The Cochrane Collaboration, Roma, Italy

  3. 3

    The Cochrane Collaboration, Cochrane Editorial Unit, London, UK

*Roger E Thomas, Department of Family Medicine, Faculty of Medicine, University of Calgary, UCMC, #1707-1632 14th Avenue, Calgary, Alberta, T2M 1N7, Canada. rthomas@ucalgary.ca.

Publication History

  1. Publication Status: New search for studies and content updated (conclusions changed)
  2. Published Online: 22 JUL 2013

SEARCH

[Figure 1]
Figure 1. Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.
[Figure 2]
Figure 2. Methodological quality summary: review authors' judgements about each methodological quality item for each included study.
[Analysis 1.1]
Analysis 1.1. Comparison 1 HCWs offered vaccination versus HCWs offered no vaccination: experimental design; data for periods of high influenza activity (Carman and Potter 152; Lemaitre 118 days), Outcome 1 Influenza.
[Analysis 1.2]
Analysis 1.2. Comparison 1 HCWs offered vaccination versus HCWs offered no vaccination: experimental design; data for periods of high influenza activity (Carman and Potter 152; Lemaitre 118 days), Outcome 2 Lower respiratory tract infection.
[Analysis 1.3]
Analysis 1.3. Comparison 1 HCWs offered vaccination versus HCWs offered no vaccination: experimental design; data for periods of high influenza activity (Carman and Potter 152; Lemaitre 118 days), Outcome 3 Admission to hospital for respiratory illness.
[Analysis 1.4]
Analysis 1.4. Comparison 1 HCWs offered vaccination versus HCWs offered no vaccination: experimental design; data for periods of high influenza activity (Carman and Potter 152; Lemaitre 118 days), Outcome 4 Deaths from influenza or its complications.
[Analysis 2.1]
Analysis 2.1. Comparison 2 HCWs offered vaccination versus HCWs offered no vaccination: experimental design; data for periods of high influenza activity (Carman and Potter 152; Lemaitre 118 days), Outcome 1 Influenza.
[Analysis 2.2]
Analysis 2.2. Comparison 2 HCWs offered vaccination versus HCWs offered no vaccination: experimental design; data for periods of high influenza activity (Carman and Potter 152; Lemaitre 118 days), Outcome 2 Pneumonia.
[Analysis 2.3]
Analysis 2.3. Comparison 2 HCWs offered vaccination versus HCWs offered no vaccination: experimental design; data for periods of high influenza activity (Carman and Potter 152; Lemaitre 118 days), Outcome 3 Admission to hospital for respiratory illness.
[Analysis 2.4]
Analysis 2.4. Comparison 2 HCWs offered vaccination versus HCWs offered no vaccination: experimental design; data for periods of high influenza activity (Carman and Potter 152; Lemaitre 118 days), Outcome 4 Deaths from influenza or its complications.